Qualitek Labs
Key Fundamentals
SMECommercial ServicesServicesPrice-based figures as of · TTM
- ROCE
- 12.10%
- Debt to Equity
- 0.61
- EPS (TTM)
- —
- Book Value
- ₹130.81
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 3.82
- ROE
- 11.50%
- Dividend Yield
- 0.00%
- EBITDA
- ₹29.90 Cr
- 52W High
- ₹650.00
- 52W Low
- ₹81.00
- Day Range
- ₹500.00 – ₹502.00
- Volume
- 4,800
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 81/100
Category scores
- Quality
- 54
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 38
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 96
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 36
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 80
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 54
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
3- Stock is trading at 4.23 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 7 | 4 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 41.82
- Neutral
- MACD (12,26,9)
- −14.18
- Bearish
- SMA (50)
- 529.85
- Bearish
- SMA (200)
- 410.85
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +83.55% |
|---|---|
| 3Y | Irregular period |
| 1Y | +78.57% |
Net profit
| 5Y | Zero base |
|---|---|
| 3Y | Irregular period |
| 1Y | +87.50% |
Operating cash flow
| 5Y | +69.52% |
|---|---|
| 3Y | Irregular period |
| 1Y | +40.00% |
Operating margin· change in pp
| 5Y | +7.33 pp |
|---|---|
| 3Y | Irregular period |
| 1Y | +1.14 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2021 | ₹6.00 Cr |
|---|---|
| Mar 2022 | ₹12.00 Cr |
| Mar 2025 | ₹70.00 Cr |
| Mar 2026 | ₹125 Cr |
Net profit by year
| Mar 2021 | ₹0.00 Cr |
|---|---|
| Mar 2022 | ₹0.00 Cr |
| Mar 2025 | ₹8.00 Cr |
| Mar 2026 | ₹15.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2025 | Mar 2026 |
|---|---|---|
| Sales | 54 | 70 |
| Expenses | 43 | 52 |
| Operating Profit | 11 | 18 |
| OPM % | 21% | 26% |
| Other Income | 0 | 0 |
| Interest | 2 | 3 |
| Depreciation | 3 | 4 |
| PBT | 6 | 12 |
| Tax % | 26% | 17% |
| Net Profit | 5 | 10 |
| EPS (₹) | 4.09 | 8.44 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 6 | 12 | 70 | 125 |
| Expenses | 6 | 11 | 54 | 95 |
| Operating Profit | 1 | 1 | 16 | 30 |
| OPM % | 11% | 10% | 23% | 24% |
| Other Income | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 2 | 5 |
| Depreciation | 0 | 1 | 4 | 7 |
| PBT | 0 | 0 | 10 | 18 |
| Tax % | 61% | 12% | 26% | 20% |
| Net Profit | 0 | 0 | 8 | 15 |
| EPS (₹) | 16 | 1.31 | 6.31 | 11.69 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0.01 | 0.46 | 10 | 12 |
| Reserves | −1 | 0 | 77 | 141 |
| Borrowings | 11 | 17 | 50 | 94 |
| Other Liabilities | 4 | 3 | 21 | 25 |
| Total Liabilities | 14 | 21 | 158 | 271 |
| Fixed Assets | 6 | 8 | 92 | 152 |
| CWIP | 4 | 4 | 16 | 46 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 4 | 9 | 50 | 73 |
| Total Assets | 14 | 21 | 158 | 271 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | 1 | −5 | 10 | 14 |
| Investing | −6 | −2 | −60 | −50 |
| Financing | 5 | 7 | 54 | 37 |
| Net Cash Flow | 0 | 0 | 4 | 1 |
| Free Cash Flow | −5 | −7 | −13 | −31 |
| CFO/EBITDA | 244 | −363 | 75 | 63 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 69 | 67 | 150 | 124 |
| Cash Conversion Cycle | 69 | 67 | 150 | 124 |
| Working Capital Days | −701 | −432 | 25 | −10 |
| ROCE % | — | 6% | — | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Qualitek Labs insights
58 extracted metrics across FY20–FY26.
Documents
- 29 May 2025
- General announcements 19 Oct 2026
Frequently Asked Questions about Qualitek Labs
What does Qualitek Labs Ltd do?
Where is Qualitek Labs Ltd (QLL) listed?
Which sector does Qualitek Labs Ltd belong to?
What is the 52-week high and low of Qualitek Labs Ltd?
What is the Return on Equity (ROE) of Qualitek Labs Ltd?
Company Information
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544091.md for Qualitek Labs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.